A recent study suggests that individuals who discontinue popular weight-loss injections like Mounjaro or Wegovy may regain reduced body mass much more quickly than those who halt traditional diet and exercise programs.
Published data in a prominent health publication demonstrates that while overweight individuals frequently drop substantial amounts of their total mass while undergoing treatment, the weight is regained at an estimated rate of 0.8 kg per month after stopping.
"People using such medications must be informed of the danger of fast rebound weight gain when the treatment ends," warns researcher Dr. Susan Jebb.
That rate of recovery means a return to starting weight in about a year and a half.
Weighing Therapies
The study, which looked at dozens of trials involving over 9,000 of participants, contrasted the outcomes of GLP-1 agonists with conventional dieting.
The team point out that individuals who lose weight through lifestyle changes alone generally see a less rapid weight regain—perhaps 0.1 kg a month—after stopping.
Explaining the Quick Rebound
Experts believe the way of the injections accounts for the accelerated regain.
GLP-1 drugs copy a body's own chemical called glucagon-like peptide-1, which controls appetite.
"Long-term administration of GLP-1 concentrations several times higher than the body's typical production may cause the body to produce less of its own natural hormone, and may also reduce sensitivity to its actions," noted Dr. Adam Collins, a nutrition expert.
"Discontinuation of this medication leads to appetite is uncontrolled, making binge eating a significant risk."
A Chronic Condition?
Medical guidelines advise the injections for people with obesity-related medical conditions, alongside recommended lifestyle changes.
Professionals say that, given the significant potential of relapse, the treatment should be considered long-term.
This view is echoed by pharmaceutical companies, who note that the findings "underscore the long-term character of excess weight," akin to managing diseases like high blood pressure.
User Experiences
People who have stopped the medication explain a powerful resurgence of appetite.
"It was like a switch that goes on and I was suddenly starving," described an individual.
The struggle is worsened if users have not developed sustainable dietary or behavioural changes during treatment.
Growing Use
Recent estimates suggest that millions of people in the UK have used weight-loss jabs in the past year, with interest being substantial.
- Adoption is more common among women than men.
- The 40s and 50s demographic shows the highest level of interest.
- Many obtain the medications through private healthcare rather than the NHS.
In conclusion, experts stress that while the jabs are effective tools for shedding pounds, they are not a permanent cure and lasting health benefits relies on integrated behavioural changes.